Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Sep 18 2025

Full Issue

Study: Vitamin B3 Linked To A Reduction In Skin Cancer Risk

Researchers found the biggest reduction in risk among people who began taking B3 after their first skin cancer diagnosis. Other public health coverage is on the benefits of blueberries on infants' immune systems, mental health, and more.

Doctors who perform skin cancer surgeries often recommend nicotinamide — which is a form of Vitamin B3 — to their patients. It's been shown to protect cells from UV radiation damage. Now, a new study of nearly 34,000 veterans, finds this over-the-counter supplement is linked to a reduction in non-melanoma skin cancers among people who've already had skin cancer. The research was published in JAMA Dermatology. (Aubrey, 9/17)

In other health and wellness news —

Feeding infants blueberries as one of their first solid foods could help strengthen their immune systems and support long-term gut health, according to new research from the University of Colorado Anschutz. The clinical trial—published in the journal Nutrients and Frontiers in Nutrition—is the first to rigorously test the effects of a specific food on infant health using a double-blind, randomized, placebo-controlled design. (Gray, 9/16)

Environmental scientists say there is no credible evidence that mifepristone (Mifeprex) or fetal tissue is contaminating U.S. water supplies at levels that would harm humans, animals, or the environment, despite claims from advocacy groups linking at-home abortions to water pollution. The debate was revived after the release of the latest "Make America Healthy Again" (MAHA) report overseen by HHS Secretary Robert F. Kennedy Jr., which raises broad concerns about pharmaceutical pollution but makes no mention of mifepristone, abortion, or fetal tissue. (McCreary, 9/16)

Researchers at the Indian Institute of Technology Gandhinagar, in collaboration with Sri Sri Institute of Advanced Research and Fortis Escort Heart Institute, report that rhythmic breathing in Sudarshan Kriya Yoga (SKY) produces measurable shifts in brain rhythms associated with deep relaxation. The team finds that SKY practice increases theta and delta brain activity while reducing alpha power. (Jackson, 9/17)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ